Azimuth Divides Media Opinion
Galnet

Azimuth Divides Media Opinion

Editorial pieces published by newsfeeds across the core systems illustrate a range of viewpoints on current events in HIP 22460.

Eye on Achenar: “There is no doubt that the real threat to our Empire will arise once the Thargoids are gone. That’s when Federal aggression will undoubtedly resume, fuelled by centuries of envy at our glorious splendour.”

Citizens' Chronicle: “Some may have mocked Princess Aisling Duval for describing Salvation as ‘a master of self-promotion and public manipulation’. But her political instincts are astute, and we believe she is right to warn us against this dangerous man.”

Sol Today: “We can all see what will happen as soon as the Thargoids have been dealt with. The Imperials will declare war against our democracy, seeking to enforce their totalitarian regime upon freedom-loving Federal citizens.”

Federal Free Press: “The government’s focus on Salvation means that vital domestic issues are being ignored. Our economy is still geared toward military spending rather than helping those families and communites who rely on state support.”

Old Worlds Gazette: “Cooperating with Sirius Corporation to harvest meta-alloys in the Coalsack Nebula was the primary cause of increased hostility from the Thargoids. Is the Alliance responsible for providing the conditions that allowed Salvation to obtain such power?”

The Tau Ceti Journal: “Senior figures in the business sector are concerned that Azimuth Biotech, despite some recent market uncertainty, has the potential to become the most influential corporation with all three superpowers. Its success in the HIP 22460 system could reshape the financial markets considerably.”

The Empirical: “Ram Tah has published theoretical papers on the Guardian technology derived from the Proteus experiments. However, he admits that full comprehension of the superweapon’s construction requires scientific data held exclusively by Salvation.”

Please update your cookie consent options to enable marketing cookies in order to view this form.

Renew or change your cookie consent